Avenue Therapeutics to Participate in Maxim Group’s 2024 Healthcare Virtual Summit

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

MIAMI, Oct. 09, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer of Avenue Therapeutics, will participate in a fireside chat at Maxim Group’s 2024 Healthcare Virtual Summit on Tuesday, October 15, 2024 at 1:30 PM ET.

The fireside chat will be available to registered attendees. Investors may sign-up or log-in to the conference here.

About Avenue Therapeutics
Avenue Therapeutics, Inc. (Nasdaq: ATXI) is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases. It is currently developing three assets including AJ201, a first-in-class asset for spinal and bulbar muscular atrophy, BAER-101, an oral small molecule selective GABAA α2, α3 receptor positive allosteric modulator for CNS diseases, and IV tramadol for the management of acute postoperative pain in adults in a medically supervised healthcare setting. Avenue is headquartered in Miami, FL and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). For more information, visit www.avenuetx.com.

Contact:
Jaclyn Jaffe
Avenue Therapeutics, Inc.
(781) 652-4500
ir@avenuetx.com

Staff

Recent Posts

Cosmo Appoints Federico Sommariva as Chief Legal Counsel

Dublin, Ireland--(Newsfile Corp. - April 1, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43)…

3 hours ago

Teaching Doctors in the World’s Fastest-Growing Economy – Texila American University in Guyana

GEORGETOWN, Guyana, March 31, 2025 /PRNewswire/ -- As Guyana rockets to the top of the…

11 hours ago

Healthcare Sector Faces Escalating Cybersecurity Risks Amid Digital Transformation

Advanced Security Solutions and Regulatory Compliance Key to Strengthening Resilience LONDON, March 31, 2025 /PRNewswire/…

11 hours ago

Living with a Bleeding Disorder

MISSION, Kan., March 31, 2025 /PRNewswire/ -- (Family Features) Many people don't think much about…

11 hours ago

Aetion Launches Aetion® Evidence Platform Availability in AWS Marketplace, Accelerating Real-World Evidence Benefits for its Customers

Aetion's industry-leading platform integrates advanced analytics, scalable workflows and actionable insights empowering organizations to unlock…

11 hours ago

Eargo and hearX Close Merger, Announce New Combined Company, LXE Hearing

Two national hearing health brands combine to make high-quality hearing aids more accessible and affordable…

11 hours ago